• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G179
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Twiddlers Syndrome (2114)
Event Date 12/21/2018
Event Type  Injury  
Manufacturer Narrative
This investigation is ongoing.Upon further information this investigation will be updated.
 
Event Description
It was reported that an alert was received via the remote monitoring system indicating anti-tachycardia pacing (atp) had been delivered.Review of the event found evidence of oversensing on the right atrial right ventricular (rv) and left ventricular (lv) leads.Some changes in impedance measurements were also noted in the preceding months, though no out-of-range measurements were reported.Upon presentation to clinic for review, all leads demonstrated atrial sensing in addition to loss of capture.An x-ray was performed confirming all leads had dislodged as a result of the patient twiddling their device.All therapy was programmed as the patient is not pacemaker dependent.A revision procedure is planned in the coming weeks.No adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that an alert was received via the remote monitoring system indicating anti-tachycardia pacing (atp) had been delivered.Review of the event found evidence of oversensing on the right atrial right ventricular (rv) and left ventricular (lv) leads.Some changes in impedance measurements were also noted in the preceding months, though no out-of-range measurements were reported.Upon presentation to clinic for review, all leads demonstrated atrial sensing in addition to loss of capture.An x-ray was performed confirming all leads had dislodged as a result of the patient twiddling their device.All therapy was programmed as the patient is not pacemaker dependent.A revision procedure was later performed during which the chronic leads were explanted and replaced; the device was reimplanted subpectorally and sutured in place.The leads were not made available for return following the procedure.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8300232
MDR Text Key134864225
Report Number2124215-2019-01564
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/11/2018
Device Model NumberG179
Device Catalogue NumberG179
Device Lot Number150419
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/21/2018
Initial Date FDA Received02/02/2019
Supplement Dates Manufacturer Received02/14/2019
Supplement Dates FDA Received04/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-